Elevated chemokine receptor CXCR4 expression in primary tumors following neoadjuvant chemotherapy predicts poor outcomes for patients with locally advanced breast cancer (LABC)

By Holm Neal   Abreo Fleurette   Johnson Lester   Li Benjamin   Chu Quyen  

Breast Cancer Research and Treatment, Vol. 113, Iss. 2, 2009-01 ,pp. : 293-299

Springer Publishing Company

Access to resources Recommend Favorite

The surgical management of patients following neoadjuvant chemotherapy for locally advanced breast cancer

By Sauven P.  

European Journal of Cancer, Vol. 38, Iss. 18, 2002-12 ,pp. : 2371-2374

Elsevier

Access to resources Recommend Favorite

Biological considerations in locally advanced breast cancer treated with anthracycline-based neoadjuvant chemotherapy: thymidine labelling index is an independent indicator of clinical outcome

By Ozmen V.  

Breast Cancer Research and Treatment, Vol. 68, Iss. 2, 2001-07 ,pp. : 147-157

Springer Publishing Company

Access to resources Recommend Favorite

Methylated DNA and high total DNA levels in the serum of patients with breast cancer following neoadjuvant chemotherapy are predictive of a poor prognosis

By                        

Oncology Letters, Vol. 8, Iss. 1, 2014-01 ,pp. : 397-403

Spandidos Publications

Access to resources Recommend Favorite

Changes in serum thymidine kinase 1 levels during chemotherapy correlate with objective response in patients with advanced gastric cancer

By                  

Experimental and Therapeutic Medicine, Vol. 2, Iss. 6, 2011-01 ,pp. : 1177-1181

Spandidos Publications

Access to resources Recommend Favorite